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Introduction
Urinary tract infections (UTIs) are among the most common se-
rious pathogenic infections in the Western world. UTIs affect a 
broad demographic, including infants, children, and the elderly, 
but women are at higher risk, nearly 40 times higher than men, 
for acquiring the disease (Foxman et al., 2000). It is estimated 
that a third of all women with UTIs have recurrent infections 
within the first 6 mo after initial antibiotic treatment. Although 
multiple uropathogens have been implicated as causative agents, 
>80% of UTIs are caused by Escherichia coli expressing fila-
mentous adhesion units termed type I fimbriae (Johnson, 1991). 
These fimbriae are thought to initiate chronic UTIs by mediat-
ing the adherence of E. coli to the bladder epithelium, and avail-
able evidence suggests that fimbriae-mediated adherence can   
be followed by invasion of the bacterium into the urothelium   
(Connell et al., 1996; Mulvey et al., 2001; Dhakal et al., 2008). 
This intracellular invasion presumably leads to a quiescent in-
fection, in which the intracellular bacteria are inaccessible to 
host immune cells or cell-impermeable antibiotics. The invasive 
nature of these infections may explain, at least in part, the fre-
quent reoccurrence of UTIs and the greater incidence of anti-
biotic resistance.
Emerging evidence implicates the cell membrane–associated 
endocytotic machinery in the invasion (entry) of bacteria into 
the host cell (Mulvey, 2002; Dhakal et al., 2008). This cellular 
machinery, typically involved in endocytosis of membrane-
bound receptors or other membrane components, may include 
cavelike lipid rafts (e.g., caveolae) and clathrin-coated pits.   
I
nvasion of bladder epithelial cells by uropathogenic 
Escherichia  coli  (UPEC)  contributes  to  antibiotic- 
resistant and recurrent urinary tract infections (UTIs), 
but this process is incompletely understood. In this paper,   
we  provide  evidence  that  the  large  guanosine  tri-
phosphatase  dynamin2  and  its  partner,  endothelial   
nitric  oxide  (NO)  synthase  (NOS  [eNOS]),  mediate 
bacterial entry. Overexpression of dynamin2 or treat-
ment  with  the  NO  donor  S-nitrosothiols  increases, 
whereas targeted reduction of endogenous dynamin2 
or eNOS expression with ribonucleic acid interference 
impairs, bacterial invasion. Exposure of mouse bladder 
to small molecule NOS inhibitors abrogates infection of 
the uroepithelium by E. coli, and, concordantly, bac-
teria  more  efficiently  invade  uroepithelia  isolated  from 
wild-type compared with eNOS
/ mice. E. coli inter-
nalization promotes rapid phosphorylation of host cell 
eNOS and NO generation, and dynamin2 S-nitrosylation, 
a posttranslational modification required for the bacte-
rial entry, also increases during E. coli invasion. These 
findings suggest that UPEC escape urinary flushing and 
immune cell surveillance by means of eNOS-dependent 
dynamin2 S-nitrosylation and invasion of host cells to 
cause recurrent UTIs.
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gentamicin protection assays (Duncan et al., 2004) to verify   
that bacterial invasion occurs through plasma membrane lipid-
rich vesicle portals. The MCD dose-dependently reduced the 
E. coli ORN103(pSH2) invasion, and the addition of cholesterol 
after MCD treatment fully restored the invasive capability 
(Fig. S1 A), which was consistent with the conclusion that intra-
cellular invasion of UPEC into BECs is mediated, at least in part, 
by caveolar portals (Duncan et al., 2004).
The large GTPase dynamin plays a central role in endo-
cytic budding of vesicles from the plasma membrane (Conner 
and Schmid, 2003), suggesting a role for dynamin in the bacte-
rial entry into host BECs. Accordingly, forced overexpression 
of ubiquitously expressed dynamin2 significantly increased the 
number of intracellular bacteria when compared with mock-
transfected controls, and, reciprocally, the overexpression of 
GTPase-deficient dominant-negative dynamin2 K44A decreased 
the E. coli ORN103(pSH2) invasion of BECs (Fig. 1 A). These 
results are supported by recent findings showing that inhibition 
of dynamin function with small molecule dynasore impairs bac-
terial invasion (Veiga et al., 2007; Eto et al., 2008). To discount 
the possibility that dynamin2 was involved in nonspecific mod-
ulation of bacterial internalization, such as increasing adher-
ence, we performed the invasion assay at 4°C, a condition that 
is not permissive for vesicle trafficking from the plasma mem-
brane into the cytosol. The results show that forced overexpres-
sion of either wild-type or K44A forms of dynamin2 does not 
impact the bacterial binding to BECs (Fig. S1 B). To further 
confirm that dynamin2 specifically affects endocytotic entry,   
we assessed the effects of overexpressing wild-type and K44A 
forms of dynamin2 on the entry of Salmonella typhimurium, a 
pathogen that invades cells through macropinocytosis (Francis 
et al., 1993; Pizarro-Cerdá and Cossart, 2006), a dynamin2- 
independent process. Results show that S. typhimurium entry 
into BECs is unaffected by the forced overexpression of wild-
type or K44A forms of dynamin2 (Fig. S1 C), reinforcing the 
idea that dynamin2-mediated vesicle trafficking is used during 
invasion from the plasma membrane.
To  directly  implicate  the  exploitation  of  host  BEC   
dynamin2 during the UPEC invasion, we modulated endogenous   
dynamin2 expression with small hairpin RNA (shRNA) and 
used clinical UPEC isolates. We used three commercially ob-
tained  lentiviruses  that  express  dynamin2-specific  shRNA 
(Dyn2shRNA) or a control shRNA that targets GFP (GFP-
shRNA).  Immunoblotting  of  cell  lysates  indicated  a  >80%   
reduction in dynamin2 protein levels by Dyn2shRNA in com-
parison with GFPshRNA (Fig. S1 D). The stable dynamin2 
knockdown BEC line D2-6649 was used to confirm the function 
of dynamin2 in the UPEC invasion. Bacterial invasion assays 
were performed with the UPEC strains CFT073, originally iso-
lated from the blood of a woman suffering from pyelonephritis, 
and UTI89, originally isolated from a cystitis patient. We also 
used control isogenic UTI89FimH, which does not encode the 
adhesive protein FimH. Each of the UPEC strains exhibited a 
similar binding capacity to BECs expressing either GFPshRNA 
or  Dyn2shRNA  (Fig.  1  B).  As  predicted,  the  binding  of 
UTI89FimH was dramatically less than isogenic UTI89 bac-
teria (Fig. 1 B). Dyn2shRNA markedly reduced the invasion of 
Significantly, both caveolae- and clathrin-coated pit–based fis-
sion from the plasma membrane have been shown to be depen-
dent on the enzymatic activity of large GTPase dynamin proteins, 
such as dynamin2, a multidomain GTPase that catalyzes bud-
ding of endocytotic vesicles (Conner and Schmid, 2003; Doherty 
and McMahon, 2009; Mettlen et al., 2009). Dynamin2 has been 
shown to be directly involved in the internalization of viral 
pathogens, and the internalization of several viruses, including 
HIV, is inhibited when a dominant-negative form (K44A) is ex-
pressed (Pizzato et al., 2007) or when dynamin function is inhib-
ited (Miyauchi et al., 2009). During the late stages of vesicle 
formation, dynamin self-assembles into rings that encircle the 
neck of the invaginated membrane. Although the exact mecha-
nism of dynamin-mediated fission is still debated (Conner and 
Schmid, 2003), it is well established that the self-assembly of pro-
tein monomers regulates GTP hydrolysis, facilitating the detach-
ment of the invaginated neck and yielding an endocytotic vesicle.
The  ability  of  dynamin  to  mediate  fission  of  cargo- 
containing invaginated pits from the plasma membrane is par-
tially regulated by interactions with partner lipids and proteins. 
For  example,  the  central  pleckstrin  homology  domain  binds 
phosphoinositides and other proteins leading to dynamin re-
cruitment to the plasma membrane (Achiriloaie et al., 1999). 
The proline- and arginine-rich carboxy terminus binds several 
proteins, including c-Src, which phosphorylates dynamin to en-
able active receptor-mediated endocytosis (Ahn et al., 1999). 
Endothelial nitric oxide (NO) synthase (NOS [eNOS]) is another 
dynamin2-interacting protein (Cao et al., 2001), and we recently 
showed that ectopically overexpressed neuronal dynamin1 and 
neuronal NOS (nNOS) proteins in model HEK293 cells form a 
complex that regulates vesicle trafficking from the plasma mem-
brane (Wang et al., 2006).
Uropathogenic E. coli (UPEC), the causative agents of the 
vast majority of UTIs (Johnson, 1991), invade host bladder epi-
thelial cells (BECs) using a stepwise process that involves the 
binding of bacterial type I fimbriae (Connell et al., 1996; Mulvey 
et al., 2001) to specific host cell plasma membrane receptors 
(Krogfelt et al., 1990), formation of membrane invaginations, 
and fission of the budding vesicles containing UPEC into the 
cytosol (Duncan et al., 2004; Bishop et al., 2007). Physical 
transport of the UPEC from the extracellular milieu to inside the 
cell can be monitored with microscopic imaging, but knowl-
edge at the molecular level, which is required for a targeted 
pharmacological approach, remains incompletely understood. 
Here, we use BECs and intact mouse bladders in bacterial   
infection assays to show that endogenous dynamin2 regulates 
UPEC invasion via a mechanism that involves eNOS-mediated 
dynamin2 S-nitrosylation.
Results
Dynamin2 regulates the UPEC invasion
We used the laboratory reference E. coli ORN103(pSH2) strain 
that expresses type 1 fimbriae and has been demonstrated to re-
capitulate the UPEC invasion (Mulvey et al., 2001; Bishop et al., 
2007) and the cholesterol-sequestering, caveolae-disrupting 
agent methyl--cyclodextrin (MCD) in previously described 103 UPEC-induced S-nitrosylation of dynamin2 • Wang et al.
compared with healthy subjects (Lundberg et al., 1996; Wheeler 
et al., 1997). We evaluated the effects of E. coli invasion on NO 
formation in host BECs, which is produced by a NOS-catalyzed 
conversion of l-arginine to l-citrulline (Hess et al., 2005;   
Dudzinski et al., 2006). The incubation of BECs with E. coli 
ORN103(pSH2) yielded a time-dependent [
3H]l-citrulline ac-
cumulation (Fig. S2 A), with marked increases in [
3H]l-citrulline 
levels observed within 30 min of incubation. Exposure of cells 
to the generic NOS inhibitor L-NAME abolished this effect 
(Fig. 2 A), demonstrating the specific NOS-dependent NO 
formation. Unexpectedly, treatment with L-NAME also yielded 
a dose-dependent decrease in the bacterial invasion of BECs as 
compared with vehicle-treated cells (Fig. 2 B), suggesting that 
NOS and NO positively regulate the bacterial uptake.
There are three isoforms of NOS named eNOS, iNOS, 
and nNOS, and we sought to verify the enzyme involved in   
the bacteria-regulated increases in NO levels. The E. coli 
ORN103(pSH2)-mediated NO formation was confirmed using 
the fluorescent NO probe DAF-2DA (Iwakiri et al., 2006), and 
the results demonstrate rapid (15–30 min) NO accumulation 
(Fig. S2 B), suggesting eNOS, and not iNOS (Olsson et al., 
1998), mediates the NO production during the initial bacterial 
infection process. In support of this conclusion, bacterial invasion 
CFT073 and UTI89 bacteria (Fig. 1 C), providing direct evidence 
that dynamin2 is a regulator of the UPEC invasion of BECs.
Dynamin2 protein levels in BECs stably infected with 
lentivirus expressing Dyn2shRNA were restored by a vector ex-
pressing either wild-type dynamin2 (Dyn2r) or dominant-negative 
K44A dynamin2 (Dyn2-K44Ar), each with silent mutations at 
the shRNA target site (Fig. 1 D). The reintroduction of wild-
type dynamin2, but not K44A dynamin2, restored the invasive 
capacity of UTI89 into host BECs (Fig. 1 E). Together, these re-
sults provide evidence that the UPEC invasion of BECs occurs, 
at least in part, through dynamin2-dependent caveolar portal 
mobilization from the plasma membrane into the cytosol.
eNOS regulates the UPEC invasion  
of BECs
In general, bacterial infections cause significant increases in the 
expression of inducible NOS (iNOS), leading to an increased 
production of NO (Weng et al., 2009), and NO and its metab-
olites  (e.g.,  peroxynitrites)  exert  potent  antibacterial  effects 
(Fang, 1997; Chakravortty and Hensel, 2003). The increases in 
NOS activity and NO production also putatively influence in-
fections of the urinary tract by UPEC, as patients with UTIs 
have  elevated  urine  concentrations  of  NO  metabolites  when 
Figure  1.  Dynamin2  regulates  the  UPEC 
invasion  of  BECs.  (A)  Forced  overexpres-
sion  of  wild-type  (WT)  dynamin2  signifi-
cantly increases the type 1 fimbriated E. coli 
ORN103(pSH2) invasion of BECs after 1 h of 
incubation, whereas the forced overexpression 
of  GTPase-deficient  dominant-negative  dyna-
min2 K44A significantly blocks the bacterial 
entry. Data are expressed relative to control 
empty vector (EV)–expressing cells. n = 5;   
*, P < 0.05 versus empty vector values. (B and 
C) Bacterial adherence (B) or bacterial inva-
sion (C) after exposure of BECs stably express-
ing  GFPshRNA  or  Dyn2shRNA  to  CFT073, 
UTI89,  or  UTI89FimH.  For  CFT073,  data 
are  shown  relative  to  GFPshRNA-expressing 
cells. For UTI89 and UTI89FimH, data are 
shown relative to GFPshRNA-expressing cells 
that  were  incubated  with  UTI89.  n  =  3;   
*, P < 0.05 versus values from corresponding 
GFPshRNA-transfected  samples.  (D)  Rescue 
of shRNA-mediated stable knockdown of en-
dogenous dynamin2 expression with shRNA-
resistant wild-type and K44A dynamin2. BECs 
stably expressing GFPshRNA or Dyn2shRNA 
were transfected with cDNAs encoding con-
trol empty vector or shRNA-resistant wild-type 
(Dyn2r)  or  K44A  (Dyn2-K44Ar)  dynamin2. 
Cell lysates were analyzed for expression of 
dynamin2 (top) and GAPDH (bottom) proteins. 
(E) Re-expression of wild-type, but not K44A, 
dynamin2 restores bacterial invasion. n = 3;   
*,  P  <  0.05  versus  values  obtained  from   
GFPshRNA-expressing cells. Data in A–C and 
E represent means ± SEM.JCB • VOLUME 192 • NUMBER 1 • 2011   104
increased the E. coli invasion of empty vector–transfected BECs 
but did not impact the already increased bacterial invasion of 
BECs that overexpress dynamin2 (Fig. 3 A). To confirm that   
L-NAME and deta-NO do not impact bacterial growth per se, 
the bacteria were directly exposed to L-NAME or deta-NO fol-
lowed by determination of colony number. The data (unpub-
lished) demonstrate that treatment with either compound had no 
significant effect on the E. coli growth. Hence, the eNOS- and 
dynamin2-regulated E. coli entry appears to be interrelated in 
that the dynamin2-mediated increase in invasion was inhibited 
by L-NAME and was not further increased after treatment with 
deta-NO (Fig. 3 A). To add confidence to the conclusion that 
dynamin2 and eNOS collaboratively regulate the UPEC inva-
sion, we targeted the expression of both with shRNA (Fig. S3 A). 
The reduction of dynamin2 and eNOS expression exhibited   
little effect on the UPEC binding to BECs (Fig. S3 B). Also, the 
knockdown of both dynamin2 and eNOS expression attenuated 
the UPEC invasion by 40–60% (Fig. 3 B), a magnitude similar 
to the effect of knocking down the individual dynamin2 and 
eNOS (Fig. S3 C). Together, these findings demonstrate that   
inhibition of eNOS activity decreases, and elevated NO levels 
increase, the E. coli invasion.
eNOS regulates the UPEC invasion of 
mouse bladder
To begin to provide a link of our in vitro results (which cred-
ibly implicate dynamin2 and eNOS in the UPEC invasion of 
of BECs prompted the rapid phosphorylation of eNOS on S1177 
(Fig. 2 C), which was indicative of its activation. To directly 
implicate eNOS in the bacterial invasion, we suppressed ex-
pression  of  the  endogenous  eNOS  gene  using  adenovirus- 
encoded shRNA (eNOSshRNA; Zhang et al., 2006). Western 
blot analysis of cell lysates showed a >60% reduction in eNOS 
protein levels by the eNOSshRNA in comparison with GFPshRNA 
(Fig. 2 D). To establish a role for eNOS in an actual UPEC in-
fection,  CFT073,  UTI89,  and  control  UTI89FimH  clinical 
UPEC isolates were used in the gentamicin protection assay.   
No  significant  differences  in  the  binding  ability  between 
eNOSshRNA- and control GFPshRNA-expressing BECs were 
observed among the UPEC strains (Fig. 2 E). However, the 
eNOSshRNA significantly attenuated the CFT073 and UTI89 
invasion of target BECs but did not further reduce the already 
low invasion of UTI89FimH (Fig. 2 F). Together, these results 
show that E. coli invasion activates eNOS, which mediates the 
UPEC invasion of host BECs.
To gain confidence in the contribution of NOS/NO and 
dynamin2 to UPEC entry into host cells, invasion assays were 
performed  using  BECs  stably  overexpressing  dynamin2  or 
empty vector control in the presence or absence of the NOS   
inhibitor L-NAME or the NO donor S-nitrosothiol deta-NO. 
Treatment with L-NAME significantly attenuated the E. coli  
invasion of empty vector–transfected BECs and reversed the 
dynamin2 overexpression–mediated increases in bacterial inva-
sion (Fig. 3 A). Moreover, treatment with deta-NO significantly   
Figure  2.  eNOS  regulates  the  UPEC  inva-
sion of BECs. (A) Enhanced enzymatic activity 
of eNOS in response to incubation of BECs 
with E. coli ORN103(pSH2), as determined by 
production of the NOS byproduct  l-citrulline. 
NI, not infected; I, infected; and I + L-NAME, 
BECs were infected with bacteria in the pres-
ence of 100 µM L-NAME. n = 4; *, P < 0.01 
versus  uninfected  BECs;  and  **,  P  <  0.05 
versus  infected  BECs.  (B)  Bacterial  invasion 
after exposure of BECs treated or not treated 
with  escalating  doses  of  L-NAME  to  E.  coli 
ORN103(pSH2). Data are expressed relative 
to control untreated BECs. n = 5; *, P < 0.05 
versus not treated (NT) cells. (C) Bacterial in-
vasion promotes the rapid phosphorylation of 
host BEC eNOS. BECs were mixed with E. coli 
ORN103(pSH2) for the indicated times, and 
equal  amounts  of  cell  lysate  were  analyzed 
by immunoblotting with anti-phosphoSer1177 
eNOS (p-eNOS; top) or anti-GAPDH (bottom) 
antibodies. (D) BECs infected with adenovirus 
encoding control GFPshRNA or eNOSshRNA 
were  analyzed  by  immunoblotting  with  anti-
eNOS  (top)  or  anti-GAPDH  (bottom)  anti-
bodies. (E and F) Bacterial adherence (E) or 
bacterial invasion (F) after exposure of BECs 
stably expressing GFPshRNA or eNOSshRNA 
to  the  UPEC  strains  CFT073,  UTI89,  or  iso-
genic control UTI89FimH. For CFT073, data 
are  shown  relative  to  GFPshRNA-express-
ing cells. For UTI89 and UTI89FimH, data 
are  shown  relative  to  GFPshRNA-expressing 
cells that were incubated with UTI89. n = 4;   
*, P < 0.01 versus values from corresponding 
GFPshRNA-transfected  samples.  Data  repre-
sent means ± SEM.105 UPEC-induced S-nitrosylation of dynamin2 • Wang et al.
animals showed no difference in the expression levels of dyna-
min2 proteins (Fig. 3 E). Together, these results provide evi-
dence that eNOS, like dynamin2, regulates the UPEC entry into 
bladder epithelium.
UPEC promote dynamin2 S-nitrosylation
NO activates soluble guanylate cyclase to synthesize cGMP, 
which, in turn, mediates many of the cellular effects of NO 
(Hess et al., 2005; Dudzinski et al., 2006). Therefore, we tested 
the effect of cGMP on E. coli ORN103(pSH2) internalization. 
Exposure of BECs to the cGMP analogue 8-parachlorophenyl-
thio-cGMP did not impact the ability of E. coli to internalize 
(unpublished data), suggesting that alternate NO-regulated 
mechanisms play a role in the bacterial invasion. Emerging evi-
dence demonstrates that NOSs or chemical NO donors, such as 
S-nitrosothiols, affect target function by S-nitrosylation of   
selective proteins (Hess et al., 2005; Dudzinski et al., 2006; 
Iwakiri et al., 2006), and we have recently demonstrated the   
S-nitrosylation of ectopically expressed neuronal dynamin1 
cultured BECs) to biology, we isolated mouse bladder for use in   
ex vivo UPEC invasion assays. The mouse bladder was surgically 
removed  and  dissected  to  isolate  the  transitional  epithelium 
layer, which is the contact site of urine-contained UPEC and the 
bladder sac. The isolated epithelial tissue was equally dissected 
into strips, which were individually pretreated or not pretreated 
with escalating doses of two distinct NOS inhibitors, L-NIO 
or L-NAME. The tissues were then exposed to E. coli and ana-
lyzed  for  bacterial  invasion  using  the  gentamicin  protection   
assay. Results demonstrate that treatment with L-NIO (not de-
picted) or L-NAME (Fig. 3 C) dose-dependently attenuated the 
bacterial invasion of mouse bladder epithelium.
To further implicate eNOS in the UPEC invasion of   
mouse bladder, we compared the bacterial uptake in bladders 
of eNOS
/ and isogenic control littermates using the ex vivo 
UPEC invasion assay. Results show that UTI89 bacteria invaded 
eNOS
/ uroepithelia substantially less than uroepithelia from 
control littermate bladders (Fig. 3 D). Immunoblotting of iso-
lated uroepithelia lysates from eNOS
/ and littermate control 
Figure 3.  eNOS controls the UPEC invasion of mouse bladder. (A) NOS and its product NO regulate the dynamin2-dependent bacterial invasion of BECs. 
Inhibition of NOS activity with 100 µM L-NAME significantly decreases the E. coli ORN103(pSH2) invasion of empty vector (EV)–transfected control BECs 
(open bars) as well as BECs overexpressing wild-type dynamin2 (shaded bars), and treatment with 500 µM S-nitrosothiol deta-NO increases the bacterial 
invasion of control (open bars) but not dynamin2-overexpressing BECs (shaded bars). Data shown are for n = 3; *, P < 0.05 versus untreated control empty 
vector–expressing BECs; **, P < 0.01 versus untreated control empty vector–transfected BECs; and ‡, P < 0.01 versus untreated wild-type dynamin2-
overexpressing BECs (all by ANOVA). (B) Bacterial invasion after exposure of BECs expressing GFPshRNA or dynamin2shRNA/eNOSshRNA to the UPEC 
strains CFT073, UTI89, or isogenic control UTI89FimH. For CFT073, data are shown relative to GFPshRNA-expressing cells. For UTI89 and UTI89FimH, 
data are shown relative to GFPshRNA-expressing cells that were incubated with UTI89. n = 3; **, P < 0.05 versus values from corresponding GFPshRNA-
transfected samples. (C) L-NAME attenuates the bacterial invasion of mouse bladder epithelium. Isolated strips of the bladder transitional epithelium layer 
were either incubated or not incubated with L-NAME and E. coli ORN103(pSH2) for 2 h followed by the determination of bacterial invasion using the gen-
tamicin protection assay. Data for each treatment group were pooled from five animals; *, P < 0.05 versus untreated samples by ANOVA (NT, not treated). 
(D) eNOS
/ bladders exhibit a decreased invasiveness by UPEC. Bladders from eNOS
/ and isogenic control mice were harvested, and transitional 
epithelium layers were isolated and used for invasion by the UPEC UTI89. Bacterial invasion was assessed by gentamicin protection assay followed by 
colony counts. n = 4; *, P < 0.01 versus wild-type (WT) animals. CFU, colony-forming unit. (E) The level of dynamin2 protein expression is not changed in 
bladder epithelia obtained from eNOS knockout (eNOS
/) compared with wild-type mice. Data in A–D represent means ± SEM.JCB • VOLUME 192 • NUMBER 1 • 2011   106
S-nitrosylation in a time-dependent manner (Fig. 4 C), suggest-
ing UPEC involvement in the S-nitrosylation of endogenous 
dynamin2. Notably, the incubation of BECs with noninvasive 
UTI89FimH bacteria also induced the S-nitrosylation of en-
dogenous dynamin2, albeit considerably less than the parental 
UTI89 bacteria (Fig. 4 D). To add support to the conclusion that 
eNOS mediates the UPEC-dependent dynamin2 S-nitrosylation, 
we analyzed the S-nitrosylation signal in bladder epithelia iso-
lated from eNOS
/ and littermate control mice, which were   
either subjected or not subjected to UTI89 invasion. Results 
show that UTI89 promoted the significant S-nitrosylation of   
dynamin2 in bladder epithelium isolated from wild-type but   
not eNOS
/ animals (Fig. 4 E).
To examine the locus of the UPEC-mediated dynamin2   
S-nitrosylation, BECs expressing individual wild-type, C86A, 
C607A,  or  C86/C607A  dynamin2  forms  were  mixed  with   
E. coli. As expected, the addition of bacteria to cells in the absence 
of exogenous NO donors revealed significant S-nitrosylation of 
wild-type dynamin2 (Fig. 5 A). Distinctly, the E. coli–induced 
S-nitrosylation signal was drastically reduced in dynamin2 C86A 
and C607A forms (Fig. 5 A), demonstrating that E. coli facili-
tate the dynamin2 S-nitrosylation mainly at the C86 and C607 
residues. These results support the conclusion that dynamin2   
in model HEK293–nNOS cells in a receptor activation–dependent 
fashion (Wang et al., 2006). Treatment of BECs with the   
S-nitrosothiol CysNO (Whalen et al., 2007) induced S-nitrosylation 
of dynamin2 in a dose-dependent manner (Fig. 4 A). To identify 
sites of nitrosylation, we created dynamin2 forms containing indi-
vidually mutated cysteine residues and found that S-nitrosylation 
of dynamin2 is highly localized to C86 residue, as evident by 
the almost complete lack of S-nitrosylation signal in the dynamin2 
C86A form (Fig. 4 B). S-nitrosylation was also observed to   
occur at residue C607, albeit to lesser levels (Fig. 4 B), and no 
S-nitrosylation signal could be detected in the dynamin2 protein 
that contained double C86/607A mutations (Fig. 4 B). These 
observations are consistent with a study showing the in vitro   
S-nitrosylation of purified dynamin2 on C86 and C607 (Kang-
Decker et al., 2007) but are distinct from those of neuronal 
dynamin1, which we previously demonstrated is only signifi-
cantly S-nitrosylated at the C607 residue (Wang et al., 2006).
To determine what, if any, role dynamin2 S-nitrosylation 
may have in the UPEC invasion, we examined the S-nitrosylation 
content of endogenous dynamin2 upon incubation of UPEC 
with BECs. Although a minimal level of endogenous dynamin2 
S-nitrosylation could be detected in uninfected BECs, infec-
tion with UTI89 caused a significant increase in the dynamin2   
Figure  4.  UPEC  invasion  promotes  the  dynamin2  S-nitrosylation  at  C86  and  C607  residues.  (A)  S-nitrosylation  of  HA-tagged  wild-type  dynamin2   
was increased with escalating doses of CysNO, as measured by the biotin-switch method (top). Equal amounts of cell lysate were immunoblotted with 
anti-HA antibody to show the equal protein loading across all lanes (bottom). (B) S-nitrosylation of dynamin2 is localized to the C86 and C607 residues of 
dynamin2. BECs were transiently transfected with cDNAs encoding HA-tagged dynamin2 (wild-type [WT], C86A, C607A, or C86/607A) and subjected 
to S-nitrosylation by 5 µM CysNO as described in A. (C and D) UPEC promote the time-dependent S-nitrosylation of endogenous dynamin2. BECs were 
incubated with UTI89 (C) or UTI89FimH (D) for the indicated times, and endogenous dynamin2 was subjected to S-nitrosylation analysis using the biotin-
switch method. 1 µM CysNO-treated cell extracts was used as a positive control, and total dynamin2 protein is shown on the bottom. (E) UTI89 induces 
the eNOS-dependent S-nitrosylation of dynamin2 in mouse bladder. Strips of the bladder transitional epithelium layer were harvested from wild-type and 
isogenic eNOS
/ mice and incubated with UTI89. After 1-h incubation, S-nitrosylation of endogenous dynamin2 was assessed by the biotin-switch method 
(top). Treatment with CysNO served as a positive control, and total dynamin2 was similar between groups (bottom). SNO, S-nitrosylated protein.107 UPEC-induced S-nitrosylation of dynamin2 • Wang et al.
the mechanisms involved in the establishment of intracellular 
bacteria communities (Anderson et al., 2004) is essential for 
combating the steady increase in antibiotic resistance and occur-
rence of recurrent UTIs. Here, we show that UPEC activate host 
epithelial cell eNOS leading to S-nitrosylation–regulated dynamin2   
activation to facilitate the bacterial invasion.
The exact plasma membrane–derived vesicle portals in-
volved in the transport of extracellular UPEC to the inside of 
BECs remains poorly elucidated, although recent work suggests 
Lamp1
+ endosomes (Mysorekar and Hultgren, 2006), fusiform 
vesicles (Bishop et al., 2007), and caveolar lipid rafts (Duncan 
et al., 2004) may be involved. Nonetheless, participant media-
tors of the fission of these UPEC-containing budding vesicles 
from the plasma membrane remain incompletely identified even 
after decades of study, and our findings identified host cell   
enzymes dynamin2 and eNOS as principal regulators of the 
bacteria-containing vesicle entry into BECs. The eNOS directly 
binds dynamin2 (Cao et al., 2001) and may serve as an anchor 
for dynamin2 stabilization and polymerization at the plasma 
membrane, thereby allowing dynamin2 to exercise its function 
of cleaving the bacteria-containing vesicles from the plasma 
membrane. Indeed, there is an enrichment of HA-dynamin2 
proteins  at  sites  of  bacterial  attachment  and  entry  into  host 
BECs (Fig. S5 A). Hence, UPEC may activate eNOS to promote 
the assembly-linked activation of dynamin2 on the plasma 
membrane, thereby allowing establishment of intracellular 
is  modified  by  S-nitrosylation  at  C86  and  C607  and  that   
E. coli promote this S-nitrosolative event most likely through 
eNOS activation.
To establish a relationship between dynamin2 S-nitrosylation   
and E. coli entry into host BECs, we examined the effects of 
GFP-tagged dynamin2 C86A, C607A, or C86/C607A over-
expression on bacterial invasion. Results show that forced 
overexpression of GFP-tagged dynamin2 C86A, C607A, or 
C86/607A, which are all impaired in nitrosylation, like the 
dominant-negative dynamin2 K44A, caused a marked decrease 
in the number of intracellular E. coli (Fig. 5 B and Fig. S4). Col-
lectively, these results show that UPEC stimulate eNOS activ-
ity,  leading  to  the  generation  of  NO  that  S-nitrosylates  and 
activates endogenous dynamin2 to facilitate the bacterial inva-
sion of host BECs.
Discussion
UTIs are among the most common bacterial diseases, and a sub-
stantial proportion of affected individuals (primarily women) 
experience recurrent infections (Johnson, 1991; Connell et al., 
1996; Foxman et al., 2000; Mulvey et al., 2001). The majority 
of UTIs are caused by UPEC, and emerging evidence suggests 
that recurrent UTIs may be caused by intracellular bacteria that 
manage to evade urinary flushing, immune cell surveillance, 
and cell membrane–impermeable antibiotics. Hence, elucidating 
Figure 5.  Requirement of dynamin2 S-nitrosylation on C86 and C607 for E. coli entry into BECs. (A) Bacterial invasion promotes the dynamin2 S-nitrosylation 
on C86 and C607 residues. BECs were transfected with HA-tagged dynamin2 (wild-type, C86A, C607A, or C86/607A), incubated with type 1 fimbriated 
HcRed-expressing E. coli for 1 h, and subjected to dynamin2 S-nitrosylation analysis by the biotin-switch method. CysNO-treated cell extracts were used 
as a positive control. NT, not transfected; WT, wild-type dynamin2; and SNO, S-nitrosylated protein. (B) BECs were transiently transfected with cDNAs 
encoding GFP-dynamin2 (wild type, K44A, C86A, C607A, or C86/607A) fusion proteins and subjected to invasion assays with the HcRed-expressing   
E. coli. Cells were washed, fixed in formalin, and counterstained with DAPI to visualize nuclei. 100 GFP- or GFP-dynamin2–expressing cells from each group 
were randomly selected, and the number of HcRed-expressing E. coli was counted. Each point represents the percent change in intracellular bacteria in 
comparison with GFP alone–expressing BECs. n = 3; *, P < 0.05 by ANOVA. Data represent means ± SEM.JCB • VOLUME 192 • NUMBER 1 • 2011   108
and eNOS-specific inhibitors may provide a clinical benefit to 
more effectively treat recurrent UTIs, which disproportionately 
affect women and are currently incurable.
Materials and methods
DNA reagents
Complementary DNAs encoding wild-type and K44A dynamin2 were pre-
viously described (Ahn et al., 1999; Wang et al., 2006). Mutations of 
dynamin2 were created with a site-directed mutagenesis kit (QuikChange; 
Agilent Technologies) using the primers C86A sense, 5-GAGTTTTTGCA-
CGCTAAGTCCAAAAAGTTT-3;  C86A  antisense,  5-AAACTTTTTGGAC-
TTAGCGTGCAAAAACTC-3; C607A sense, 5-ATCGAACTGGCTGCTG-
ACTCCCAGGAA-3; and C607A antisense, 5-TTCCTGGGAGTCAGCA-
GCCAGTTCGAT-3.
Knockdown and rescue of dynamin2 in BECs
Lentiviral  DNA  expression  vectors  were  purchased  from  Thermo  Fisher   
Scientific. Each expression vector contained 21-nt shRNA duplexes targeting 
dynamin2:  5-GCAGTCGTACATCAACACAAA-3,  5-GCCGGAACATT-
GAACATTTAA-3, and 5-CCTTGAAGAATGTGTCCTGAT-3. 3 µg of each   
expression vector was cotransfected with equal concentrations of vesicular 
stomatitis virus G and the 8.9 vector into 293T cells using transfection 
reagent (FuGENE 6; Roche). As a negative control, 293T cells were trans-
fected with the same amount of expression vector containing a GFP-targeting 
sequence (5-GCAAGCTGACCCTGAAGTTCAT-3). After 24 h, the medium 
from transfected 293T cells was collected, mixed with 5 µl polybrene, and 
added to the BECs. New medium was added to the 293T cells for an ad-
ditional 24 h, and the BECs were infected a second time. The duration of 
viral infection of the BECs was 2 h, and then the medium was changed to 
RPMI 1640 containing 10% FBS. After 48 h, the shRNA-expressing cells 
were selected with 2 µg/ml puromycin. Plates of BECs not infected with 
virus were used in parallel treatment with puromycin as a selection control. 
When the uninfected control cells were completely killed, the infected cell   
medium was replaced with complete medium containing 1 µg/ml puro-
mycin for maintenance. The level of protein was determined by immunoblot-
ting using dynamin2-specific antibody. Knockdown-resistant dynamin2 was 
made with the site-directed mutagenesis kit (QuikChange) without chang-
ing the coding amino acids (5-GCAGTCCTACATCAACACGAA-3).
Knockdown of eNOS expression in BECs
Adenoviruses encoding shRNA that target human eNOS sequences (gift 
from D. Fulton, Medical College of Georgia, Augusta, GA) were used to 
infect BECs (Zhang et al., 2006). Cells were harvested after 36 h of infec-
tion, and lysates were used to confirm the decreased expression of eNOS 
protein by immunoblot analysis.
Bacteria strains and cell culture
The laboratory isolate E. coli K-12 derivative ORN103(pSH2), containing 
a deletion of the type 1 fimbrial gene cluster and transformed with plasmid 
pSH2, which encodes type 1 fimbrial gene clusters plus a chloramphenicol 
resistance marker, E. coli ORN103(pSH2) expressing pHcRed (gift from   
S. Abraham, Duke University, Durham, NC; Duncan et al., 2004), and three 
clinical strains, UTI89, UTI89FimH, and CFT073 (gift from M. Mulvey, 
University of Utah, Salt Lake City, UT), were used at an MOI of 10–50. The 
human bladder epithelial cancer cell line 5637 (BEC) was obtained from 
American Type Culture Collection (HTB-9) and was cultured in RPMI 1640 
medium supplemented with 10% FBS without antibiotics at 37°C in a humid-
ified atmosphere of 5% CO2. Cells were transfected using the appropriate   
cDNAs and Lipofectamine (Invitrogen), and experiments were performed   
1 d after transfection.
Bacteria cell association and invasion assays
BECs were seeded at 5 × 10
4 cells per well in 96-well plates and allowed 
to grow to confluence. Cells were serum starved overnight in culture me-
dium containing 10 mM Hepes, pH 7.5, and 0.1% BSA and infected upon 
addition of the indicated bacteria strain for 1 h at 37°C. For bacterial cell 
association measurement, BECs were collected by centrifugation, washed 
four times with PBS, and lysed in PBS containing 0.25% (volume per vol-
ume) Triton X-100. Dilutions (1:10 and 1:100) of lysates were plated on 
Luria broth agar plates with chloramphenicol, and colonies were allowed 
to grow and counted the next day. To determine the number of internalized 
bacteria, cell culture medium containing infecting bacteria was replaced 
with fresh medium containing 100 µg/ml of membrane-impermeable   
UPEC communities (Anderson et al., 2004) that cause recurrent 
UTIs. In support of this idea, we find that bacterial invasion in-
creases the localization of wild-type, but not nitrosylation- 
deficient, dynamin2 on the plasma membrane (Fig. S5 B).
Bacterial infections, including the UPEC-acquired UTIs, 
promote substantial increases in iNOS expression and local   
NO concentrations, which act as a host cell defense mechanism 
(Fang, 1997; Wheeler et al., 1997). Our findings are suggestive 
of an iNOS-independent UPEC invasion into BECs: UPEC entry 
occurs within minutes of infection, a time frame that is insuffi-
cient to markedly alter iNOS protein expression and promotes 
only a modest, albeit significant, increase in NO levels. Rather, 
the results are consistent with the idea that eNOS exerts a critical 
role in the UPEC invasion of BECs: the E. coli phosphorylate 
eNOS on S1177, and knockdown of eNOS expression attenuates 
UPEC invasion. More to the point, the UPEC invasion of uro-
epithelia isolated from eNOS
/ mice is significantly less than 
that of littermate control animals, and, in contrast, it has been   
reported that iNOS
/ animals exhibit high susceptibility to bacte-
rial infections (Fang, 1997; Chakravortty and Hensel, 2003). 
Furthermore, iNOS and eNOS are distributed to distinct sub-
cellular compartments, and a recent study showed that protein 
nitrosylation is confined to the primary site of eNOS localization 
(Iwakiri et al., 2006). Hence, the source of NO (iNOS vs. eNOS) 
and amount of NO may dictate the host cell response and fate of 
the invasive bacteria. Low concentrations of NO, generated by 
eNOS, act to facilitate bacterial entry, whereas high NO levels, 
later generated by iNOS, exert nonspecific and bacteriotoxic   
effects. Indeed, the present results show that uroepithelium from 
eNOS
/ mice exhibit significantly less UPEC-mediated dyna-
min2 S-nitrosylation and UPEC invasion. These observations 
are reminiscent of other biological systems wherein low NO   
levels act as signal transducers involved in the normal cellular 
physiology and high levels of NO exert pathophysiologic effects 
(Pervin et al., 2007; Thomas et al., 2008).
The present study shows that UPEC promote eNOS acti-
vation  and  dynamin2  S-nitrosylation  at  conserved  C86  and 
C607 residues and that dynamin2 S-nitrosylation appears to be 
critical for the UPEC entry into BECs. A remaining question is 
how UPEC activate host epithelial cell eNOS and dynamin2. 
Bacterial binding to host cell plasma membrane–anchored re-
ceptors is a required first step in the invasion process (Krogfelt 
et al., 1990; Connell et al., 1996). Treatment with methyl--d-
mannose, which interferes with the association of UPEC with 
host cell glycoproteins, showed no effect on the UPEC-mediated 
NO production (unpublished data), suggesting a possible exis-
tence of soluble bacteria factors that activate eNOS. Indeed, 
eNOS undergoes phosphorylation-dependent activation in re-
sponse to a diverse array of extracellular signals that converge 
to activate intracellular kinases, including Akt and the cAMP-
dependent protein kinase PKA (Michell et al., 2001). Our re-
sults show that UTI89FimH, like parental UTI89, is capable 
of promoting the cAMP accumulation (unpublished data) as 
well as dynamin2 S-nitrosylation, leading us to propose that a 
soluble UPEC factor may initiate a cAMP→PKA→eNOS→
dynamin2 activation signaling cascade, which is required for 
the UPEC invasion. Identification of dynamin2 S-nitrosylation 109 UPEC-induced S-nitrosylation of dynamin2 • Wang et al.
Statistical analysis
The significance of the treatment-induced cellular response was analyzed 
by two-way ANOVA with Bonferroni posttest and implied at P < 0.05. All 
statistical analyses were performed, and all graphs generated, using Prism 
5.0 software (GraphPad Software, Inc.). The x and y labels of all pre-
sented data were prepared using the Illustrator suite (CS2; Adobe).
Online supplemental material
Fig. S1 shows the role of caveolae and dynamin in bacterial invasion.   
Fig. S2 shows the bacteria-mediated increase in NO formation. Fig. S3 
shows the effect of knocking down the expression of dynamin2 and eNOS on 
bacteria invasion. Fig. S4 shows the requirement of dynamin2 S-nitrosylation 
for bacteria invasion. Fig. S5 shows the effect of bacteria invasion on the 
subcellular distribution of dynamin2. Online supplemental material is avail-
able at http://www.jcb.org/cgi/content/full/jcb.201003027/DC1.
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gentamicin antibiotic (to kill extracellular bacteria). After 30–60 min, cells 
were washed four times in PBS, lysed, and plated (1:10 and 1:100 dilu-
tions) on Luria broth agar plates for colony counting, and, on average, the 
colony numbers ranged from 100 to 400.
For determining the effect of dynamin2 S-nitrosylation on UPEC in-
vasion, BECs were transiently transfected with cDNAs encoding GFP- 
dynamin2 fusion proteins, seeded onto glass coverslips, and infected with 
HcRed-expressing E. coli. Cells were washed and treated with gentamicin 
(to kill extracellular bacteria) as described in the previous paragraph. Cells 
were fixed in 10% formalin solution and stained with DAPI to visualize   
nuclei. For each experiment, internalized bacteria were analyzed from 
100 randomly selected GFP-dynamin2–expressing cells. Cells expressing 
HA-dynamin2  were  stained  with  an  anti-HA  antibody  followed  by  an   
Alexa Fluor 488–conjugated secondary antibody, and cells expressing 
GFP-dynamin2 and invaded with HcRed bacteria were visualized using 
microscopy. In brief, cells were mounted using fluorescence mounting me-
dium (Dako) and were examined using a confocal microscope (TCS SP5; 
Leica) equipped with a 40×/1.25 NA oil immersion lens. Images were 
captured and analyzed using the application suite advanced fluorescence 
2.0.2 software (Leica).
For  animal  studies,  bladders  were  harvested  from  5–7-wk-old   
female C57BL/6 mice and macrodissected to isolate the transitional epi-
thelium layer. Tissues were cut into strips and placed in RPMI 1640 medium 
for infection with UPEC. To inhibit NOS activity, tissues were treated with   
L-NAME or L-NIO before mixing with the UPEC. Bladder tissues were then 
washed twice with gentamicin solution and incubated for an additional   
30 min to allow complete killing of floating and unincorporated bacteria. 
Bladder tissues were minced, lysed, and subjected to the colony formation 
assay. In all cases, levels of cell-associated or intracellular bacteria are ex-
pressed relative to control samples. All assays were repeated at least three 
times in triplicate, and significant differences between controls and experi-
mental samples were determined by analysis of variance (ANOVA; with   
P < 0.05 considered to be significant).
Immunoblotting
Total and phosphorylated protein levels were detected by immunoblotting. 
Cells were lysed in radio immunoprecipitation assay buffer (Wang et al., 
2006; Whalen et al., 2007), and whole cell lysates were subjected to pro-
tein quantification using the Bradford method. Equal amounts of protein 
were resolved by SDS-PAGE, transferred to nitrocellulose membranes, and 
immunoblotted with dynamin2 (1:1,000 dilution; Cell Signaling Technol-
ogy), phosphoSer1177-eNOS (1:500 dilution; Transduction Laboratories), 
total eNOS (1:500 dilution; Transduction Laboratories), glyceraldehyde   
3-phosphate dehydrogenase (GAPDH; 1:5,000 dilution; Millipore), or 
HA (1:5,000 dilution; Abcam) antibodies. Filters were incubated with the   
appropriate HRP-conjugated secondary antibody and developed with   
enzyme-linked chemiluminescence.
NOS activation assay
The enzymatic activity of NOS was assessed as the formation of [
3H]l-citrulline 
from the radiolabeled NOS substrate [
3H]l-arginine. BECs were incubated 
with E. coli ORN103(pSH2) in the presence of 3–5 µCi/ml [
3H]l-arginine 
(41 Ci/mmol; PerkinElmer) in a buffer containing 25 mM Hepes, pH 7.3, 
100 mM NaCl, 5.4 mM KCl, 1 mM CaCl2, 1 mM MgSO4, 25 mM glu-
cose, and 10 µM of unlabeled l-arginine. After the indicated incubation 
times, cells were washed with PBS, scraped into stop solution containing 
20 mM sodium acetate, 1 mM l-citrulline, 2 mM EDTA, and 2 mM EGTA, 
pH 5.5, and homogenized. An aliquot of the protein sample was pre-
served for the determination of protein content, and the remaining cell   
lysate was added to a column (Dowex 50W-X8 400; Bio-Rad Laboratories) 
to separate [
3H]l-citrulline. The flow-through fraction was analyzed by liquid 
scintillation counting. In addition to infected cells, each experimental condi-
tion included uninfected cells and samples of E. coli ORN103(pSH2) alone 
to account for basal BECs and E. coli [
3H]l-citrulline formation, respectively. 
For NOS inhibition experiments, cells were pretreated with 100 µM L-NAME 
overnight before the addition of [
3H]l-arginine.
Protein S-nitrosylation
Appropriately treated BECs or isolated mouse bladder transitional epithelia 
were lysed in 400 µl of lysis buffer (25 mM Hepes, pH 7.7, 50 mM NaCl,   
1 mM EDTA, 0.1 mM neocuproine, 1% NP-40, and protease inhibitor cocktail 
[Complete; Roche]). Cell/tissue extracts were diluted to 1 ml with HEN buffer 
(250 mM Hepes, 1 mM EDTA, and 0.1 mM neocuproine, pH 7.7), and detec-
tion of dynamin2 S-nitrosylation was performed using the biotin-switch method 
as we previously described (Wang et al., 2006; Whalen et al., 2007).JCB • VOLUME 192 • NUMBER 1 • 2011   110
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